Concepedia

Michal Podrazil

MP

Statistics

Publications

6

Citations

309

H-Index

6

Active since

2010

Affiliations

Charles University(Current)

University Hospital in Motol

Sotio (Czechia)

Institute of Haematology and Blood Transfusion

Délégation Paris 5

Michal Podrazil is an author at Charles University specializing in immunology, immunotherapy, and oncology.

Publications per year

2010–2022

6

Publications

6

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer

Michal Podrazil, Rudolf Horváth, Étienne Becht et al. · Oncotarget · 2015 · 136 citations · Full text

Medicine, Immunology, Oncology +17

The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro

Dmitry Stakheev, Pavla Táborská, Zuzana Střížová et al. · Scientific Reports · 2019 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer

Jitka Fučíková, Michal Podrazil, L. Jarolím et al. · Cancer Immunology Immunotherapy · 2017 · 45 citations · Full text

Medicine, Immunology, Oncology +17

Intensive physical activity increases peripheral blood dendritic cells

Ondřej Suchánek, Michal Podrazil, Barbara Fischerová et al. · Cellular Immunology · 2010 · 34 citations

Life Sciences, Immunology, Physiology +14

Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines

Michal Hensler, Jana Raková, Lenka Kašíková et al. · OncoImmunology · 2022 · 16 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 6